Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent ThrombosisPiergiovanni Buonamici, David Antoniucci, Rossella Marcucci et al.|Journal of the American College of Cardiology|2007Cited by 656
Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care AssayRossella Marcucci, Gian Franco Gensini, Rita Paniccia et al.|Circulation|2009Cited by 520
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patientsBetti Giusti, Gian Franco Gensini, Anna Maria Gori et al.|Pharmacogenetics and Genomics|2007Cited by 228
Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent ThrombosisBetti Giusti, Gian Franco Gensini, Anna Maria Gori et al.|The American Journal of Cardiology|2009Cited by 222
Incidence and Clinical Impact of Dual Nonresponsiveness to Aspirin and Clopidogrel in Patients With Drug-Eluting StentsAnna Maria Gori, David Antoniucci, Rossella Marcucci et al.|Journal of the American College of Cardiology|2008Cited by 205